@fit_2_serve's blood test TRT pitch, fact-checked
Quick answer
Testosterone replacement therapy treats clinically diagnosed hypogonadism, affecting about 2.1% of middle-aged men. The TRAVERSE trial in 2023 showed increased cardiovascular risk in the first two years of treatment. Most telehealth companies market testing to men with normal testosterone levels.
Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team· This is not a transcript. It is our independent review of the video above.
What does this video actually claim?
The @fit_2_serve TikTok doesn't make any explicit health claims. It's essentially a 15-second ad for Blokes, a men's telehealth company that offers testosterone testing and replacement therapy.
The creator uses the phrase "get your blood checked" with a discount code, suggesting viewers should test their hormone levels. The caption's vague "it be like that" paired with fitness hashtags implies low testosterone might be affecting workout performance, but there's no direct medical claim here.
This is pure marketing disguised as fitness content. The video relies on viewers making their own assumptions about testosterone and performance.
Is routine testosterone testing actually necessary?
For most men? No. The Endocrine Society's 2018 guidelines recommend testosterone testing only when you have clear symptoms of hypogonadism plus a clinical reason to suspect low T.
Normal testosterone ranges from 300-1000 ng/dL, but that's a huge range. A 25-year-old might naturally sit at 400 ng/dL and feel fine, while another needs 600 ng/dL to avoid symptoms. Your baseline matters more than hitting some arbitrary number.
The American Urological Association found that only 2.1% of men aged 40-79 actually have both low testosterone and symptoms. Most guys getting "low T" diagnoses from telehealth companies fall into normal ranges but get sold treatment anyway.
What's the deal with Blokes and similar companies?
Blokes operates like most direct-to-consumer testosterone companies. They'll test your levels, and if you're anywhere near the bottom of the normal range, they'll likely suggest TRT.
These companies have a business incentive to find problems. A 2021 analysis in JAMA Internal Medicine found that telehealth testosterone prescriptions increased 300% between 2017-2020, despite no corresponding increase in actual hypogonadism diagnoses.
The FDA has specifically warned about overprescribing testosterone to men with normal-for-age levels. Yet companies like Blokes market to younger men who probably don't need testing, let alone treatment.
Their discount codes and fitness influencer partnerships should raise red flags. Legitimate medical care doesn't usually come with promo codes.
What are the real risks of unnecessary TRT?
Testosterone replacement shuts down your natural production permanently in many cases. The TRAVERSE trial, published in NEJM in 2023, followed 5,246 men and found increased cardiovascular events in the first two years of treatment.
Even if you stop TRT, your natural testosterone might never recover. A 2019 study in BJU International found that 25% of men had persistently low testosterone even after discontinuing treatment.
You'll also need regular blood work forever. TRT increases red blood cell count, potentially raising stroke risk. It can worsen sleep apnea and accelerate prostate enlargement.
For young, healthy men with normal levels, you're trading uncertain benefits for definite lifelong medical management.
When should you actually consider testosterone testing?
Get tested if you have multiple symptoms that developed together: persistent fatigue, loss of morning erections, decreased muscle mass despite consistent training, and mood changes.
But get it done by a doctor, not a telehealth company with a financial interest in finding problems. Your physician can rule out other causes first. Depression, sleep disorders, and thyroid issues all mimic low testosterone symptoms.
If you do have low T, address reversible causes before jumping to lifelong hormone replacement. Poor sleep, obesity, and chronic stress all tank testosterone levels naturally.
Video review standard
Clinical fact-check snapshot
FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.
Evidence signal
Source-backed review
Regulatory reality
Access rules depend on the compound and patient situation
Safety screen
Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.
This page currently connects to 6 source-backed evidence items through visible references or structured citation data.
PubMed evidence trail
Research sources used to frame this page
For @fit_2_serve's blood test TRT pitch, fact-checked, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.
Cardiovascular Safety of Testosterone-Replacement Therapy
TRAVERSE trial anchor for cardiovascular-safety discussions in appropriately diagnosed men.
PubMed
Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline
Guideline anchor for diagnosis, monitoring, contraindications, and appropriate TRT framing.
PubMed
NAD+ metabolism and its roles in cellular processes during ageing
Core review for NAD+ decline, mitochondrial function, DNA repair, and aging biology.
PubMed
Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women
Human NMN source for metabolic claims while keeping population limits clear.
PubMed
Provider decision path
Use local research to choose a safer review path
Direct answer
@fit_2_serve's blood test TRT pitch, fact-checked is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.
Evidence check
Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.
Safety check
Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.
Next step
Compare providers, services and access requirements in the directory before contacting a suitable care team.
Claim path
Keep researching this testosterone and trt video claims cluster
Best for searchers turning TRT social claims into a safer lab-backed provider discussion.
Claim verdict
The useful answer behind this video
Claim being checked
Testosterone replacement therapy treats clinically diagnosed hypogonadism, affecting about 2.
FormBlends verdict
Testosterone replacement therapy treats clinically diagnosed hypogonadism, affecting about 2.1% of middle-aged men. The TRAVERSE trial in 2023 showed increased cardiovascular risk in the first two years of treatment. Most telehealth companies market testing to men with normal testosterone levels.
Patient-safe next step
Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.
What to do with this video
Use the clip as a claim to verify, not a treatment plan
What it helps with
- Testosterone replacement therapy treats clinically diagnosed hypogonadism, affecting about 2.1% of middle-aged men. The TRAVERSE trial in 2023 showed increased cardiovascular risk in the first two years of treatment. Most telehealth companies market testing to men with normal testosterone levels.
- Only 2.1% of men aged 40-79 actually have both low testosterone and symptoms requiring treatment
- The TRAVERSE trial found increased cardiovascular events in the first two years of TRT
What it may miss
- It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
- Compound access, legal status, and product quality still need a separate safety check.
- Social video captions rarely show the full evidence base behind a claim.
Best next step
Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.
Start provider reviewWhat You'll Learn
- Only 2.1% of men aged 40-79 actually have both low testosterone and symptoms requiring treatment
- The TRAVERSE trial found increased cardiovascular events in the first two years of TRT
- 25% of men who stop TRT never recover their natural testosterone production
- Normal testosterone ranges from 300-1000 ng/dL, with huge individual variation in optimal levels
- Telehealth testosterone prescriptions increased 300% from 2017-2020 despite stable hypogonadism rates
- Depression, sleep disorders, and thyroid issues can mimic low testosterone symptoms
- The FDA specifically warns against prescribing testosterone to men with normal-for-age levels
Interested in GLP-1 or peptide therapy?
Get matched with licensed-provider review to help decide if it is right for you.
About the Creator
Fit2Serve · TikTok creator
9.7K views on this video
It be like that Get your boood checked from @Get Blokes today and use code SLAUGHTER to save 💸 #fitness #menshealth #workout
Read More on This Topic
Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.
Not medical advice. This video was made by Fit2Serve, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.